37 followers
Phase I: AZD7762, a checkpoint kinase inhibitor, with gemcitabinem, advanced solid tumors. US. http://t.co/LeP3rwJORn
Phase I: AZD7762, a checkpoint kinase inhibitor, with gemcitabinem, advanced solid tumors. US. http://t.co/LeP3rwJORn
New Chk1 kinase inhibitor shows efficacy in #LungCancer but use limited by cardiac toxicity http://t.co/afojuQ0ert #lcsm